UNFOLDED PROTEIN RESPONSE IS ACTIVATED IN HEART OF CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA (CPVT) MICE

Rigers Bakiu

doi:10.5937/sjecr15-6707

Rigers Bakiu Univerzitet u Kragujevcu Medicinski fakultet

DOI: https://doi.org/10.5937/sjecr15-6707

Sažetak

ABSTRACT

Isoform 2 of calsequestrin (CSQ2), is the main calcium-binding protein of sarcoplasmic reticulum (SR), expressed both in cardiac and in skeletal muscles. CSQ2 acts as an SR calcium (Ca²⁺) sensor and regulates SR Ca²⁺ release via interactions with triadin, junctin, and the ryanodine receptor. Various mutations of the csq2 gene lead to altered Ca²⁺ release and contractile dysfunction contributing to the development of arrhythmias and sudden cardiac death in young individuals affected by CPVT. Transgenic mice carrying one of the identified CSQ2 point-mutations (R33Q) associated to CPVT were developed and a drastic reduction of the mutated protein was observed. Following a biomolecular approach several analysis were performed using different antibody treatments in order to identify when the reduction of CSQ2 begins, unveil the mechanism involved in the reduction of CSQ2 and verify if other proteins are affected by the presence of the mutated protein. This study results showed that mutated CSQ2 decreased soon after birth in conjunction with the decreased levels of other important proteins of the junctional SR, such as triadin (TD). Up-regulation of proteins associated to the unfolded protein response (UPR) was also observed and the pathway activated by UPR was the ATF6-dependent one. The R33Q mutation induced the decrease of CSQ2 by activation of the UPR and subsequently degradation through proteasome.

Keywords: Calsequestrin, CPVT, ERAD, UPR, Triadin, Chaperones.

Reference

Myerburg RJ, Conde CA, Castellanos A. Survivors of prehospital cardiac arrest. JAMA 1982; 247: 1485-90.

Zipes DP, Camm AJ, Borggrefe M, Buxton AE et al. American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and theEuropean Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: 385-84.

Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R, Sorrentino V, Danieli GA. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001; 103: 196-200.

Brunello L, Slabaugh JL, Radwanski PB et al. Decreased RyR2 refractoriness determines myocardial synchronization of aberrant Ca2+ release in a genetic model of arrhythmia. Proc Natl Acad Sci U S A. 2013;110(25): 10312-17.

Eldar M, Pras E, Lahat H. A missense mutation in the CASQ2 gene is associated with autosomal-recessive catecholamine-induced polymorphic ventricular tachycardia. Trends Cardiovasc Med 2003; 13: 148–51.

Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007; 4: 675–78.

Song L, Alcalai R, Arad M, Wolf CM, Toka O, Conner DA, Berul CI, Eldar M, Seidman CE, Seidman JG. Calsequestrin 2 (CASQ2) mutations increase axpression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia. J Clin Inv 2007; 17: 1814-23.

Cerrone M, Colombi B, Santoro M et al. Bidirectional Ventricular Tachycardia and Fibrillation Elicited in a Knock-In Mouse Model Carrier of a Mutation in the Cardiac Ryanodine Receptor. Circ Res 2005; 96: e77-82.

Rizzi N, Liu N, Napolitano C et al. Unexpected structural and functional consequences of the R33Q homozygous mutation in cardiac calsequestrin: a complex arrhythmogenic cascade in a knock in mouse model. Circ Res 2008; 13: 298-306. DOI: 10.1161/CIRCRESAHA.108.171660.

Flucher BE, Franzini-Armstrong C. Formation of junctions involved in excitation-contraction coupling in skeletal and cardiac muscle. Proc Natl Acad Sci USA 1996; 93: 8101-06.

Beard NA, Laver DR, Dulhunty AF. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 2004; 85: 33–69.

Beard NA, Wei L, Dulhunty AF. Ca(2+) signaling in striated muscle: the elusive roles of triadin, junctin, and calsequestrin. Eur. Biophys. J. 2009; 39: 27-36. DOI: 10.1007/s00249-009-0449-6.

Beard NA, Casarotto MG, Wei L, Varsányi M, Laver DR, Dulhunty AF. Regulation of ryanodine receptors by calsequestrin: effect of high luminal Ca2+ and phosphorylation. and phosphorylation. Biophys J 2005; 88: 3444-54.

Tijskens P, Jones LR, Franzini-Armstrong C. Junctin and calsequestrin overexpression in cardiac muscle: the role of junctin and the synthetic and delivery pathways for the two proteins. J Mol Cell Cardiol 2003; 35: 961-74.

Catterall WA. Structure and regulation of voltage-gated Ca2+ channels. Annu. Rev. Cell. Dev. Biol. 2000; 16: 521-55.

Terentyev D, Nori A, Santoro M, Viatchenko-Karpinski S et al. Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death. Circ Res 2006; 98: 1151-58.

Kirchhefer U, Wehrmeister D, Postma AV, Pohlentz G, Mormann M, Kucerova D, Müller FU, Schmitz W, Schulze-Bahr E, Wilde AA, Neumann J. The human CASQ2 mutation K206N is associated with hyperglycosylation and altered cellular calcium handling. J Mol Cell Cardiol 2010; 49: 95-105. DOI: 10.1016/j.yjmcc.2010.03.006.

di Barletta MR, Viatchenko-Karpinski S, Nori A, Memmi M, Terentyev D, Turcato F, Valle G, Rizzi N, Napolitano C, Gyorke S, Volpe P, Priori SG. Clinical phenotype and functional characterization of CASQ2 mutations associated with Catecholaminergic Polymorphic Ventricular Tachycardia. Circulation 2006; 114: 1012-19.

Chopra N, Yang T, Asghari P, Moore ED et al. Ablation of triadin causes loss of cardiac Ca2+ release units, impaired excitation-contraction coupling, and cardiac arrhythmias. Proc Natl Acad Sci USA 2009; 106: 7636-41. DOI: 10.1073/pnas.0902919106.

Groenendyk J, Sreenivasaiah PK, Kim do H, Agellon LB, Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ Res 2010; 107: 1185-97. DOI: 10.1161/CIRCRESAHA.110.227033.

Glembotski C. Endoplasmic reticulum stress in the heart. Circ. Res 2007; 101: 975-84.

Bertolotti A, Zhang Y, Hendershot LM, Harding HP, Ron D. Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response. Nat Cell Biol 2002; 2: 326–32.

Brodsky JL. The protective and destructive roles played by molecular chaperones during ERAD (endoplasmic-reticulum-associated degradation). Biochem J 2007; 404: 353–63.

Määttänen P, Gehring K, Bergeron JJ, Thomas DY. Protein quality control in the ER: the recognition of misfolded proteins. Semin Cell Dev Biol 2010; 21: 500-511. DOI: 10.1016/j.semcdb.2010.03.006.

Bernales, S., McDonald, K.L. and Walter, P. Autophagy counterbalances endoplasmic reticulum expansion during the unfolded protein response. PLoS Biol 2006; 4: 423.

Glembotski C. The role of the unfolded protein response in the heart. J Mol Cell Card 2007; 44: 453-59.

Gustafsson AB. Bnip3 as a dual regulator of mitochondrial turnover and cell death in the myocardium. Pediatr Cardiol 2011; 32: 267-274. DOI: 10.1007/s00246-010-9876-5.

Lee JW, Kim WH, Yeo J Jung MH. ER stress is implicated in mitochondrial dysfunction-induced apoptosis of pancreatic beta cells. Mol Cells 2010; 30: 545-549. DOI: 10